🔗 Share this article

Treasury head Rachel Reeves has stated she is planning "focused measures to deal with cost of living issues" in next month's financial statement.

During an interview with media outlets, she emphasized that curbing price rises is a collective responsibility of both the administration and the central bank.

The United Kingdom's inflation rate is projected to be the highest among the Group of Seven developed nations this year and the following year.

Possible Utility Bill Interventions

Sources suggest the administration could intervene to bring down energy bills, for example by slashing the present 5% level of value-added tax charged on energy supplies.

An additional approach is to lower some of the policy costs currently included in bills.

Budgetary Limitations and Expert Predictions

The administration will receive the next draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for these measures.

The consensus from the majority of analysts is that Reeves will have to introduce higher taxes or spending cuts in order to meet her declared debt limits.

Earlier on Thursday, calculations indicated there was a £22 billion shortfall for the chancellor to fill, which is at the more modest range of forecasts.

"It is a collective responsibility between the central bank and the government to bear down further on some of the drivers of price increases," the Chancellor stated to reporters in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and Global Issues

While much of the focus has been on likely tax rises, the Treasury chief said the most recent information from the OBR had not altered her pledge to manifesto promises not to raise rates on income tax, VAT or National Insurance.

She attributed an "unpredictable world" with increasing international and commercial issues for the fiscal revenue measures, likely to be targeted on those "wealthiest."

International Trade Tensions

Referring to worries about the UK's trade ties with the Asian nation she said: "The UK's security interests invariably take priority."

Recent statement by Chinese authorities to strengthen export controls on rare earths and other resources that are crucial for advanced tech production led American leader Donald Trump to suggest an additional 100% tariff on imports from the Asian country, raising the risk of an all-out trade war between the two largest economies.

The US Treasury Secretary called China's decision "economic coercion" and "a international production control attempt."

Inquired about considering the US offer to join its battle with the Asian nation, Reeves said she was "deeply worried" by China's actions and called on the Beijing authorities "not to put up barriers and restrict access."

She said the move was "harmful for the global economy and causes further challenges."

"I believe there are fields where we should confront Chinese policies, but there are also valuable prospects to sell into China's economy, including banking sector and other areas of the economic system. We've got to achieve that balance right."

The Treasury chief also confirmed she was cooperating with G7 counterparts "on our own essential resources strategy, so that we are more independent."

NHS Medicine Costs and Funding

Reeves also recognized that the price the National Health Service pays for pharmaceuticals could go up as a result of current talks with the US government and its pharmaceutical firms, in return for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or abandoning operations in the United Kingdom, with some blaming the insufficient payments they are getting.

Last month, the government science advisor said the price the health service spends on medicines would have to go up to prevent companies and drug research funding departing from the UK.

Reeves informed media: "It has been observed as a result of the payment system, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the manner that they are in other European countries."

"Our aim is to guarantee that people receiving treatment from the NHS are able to access the best essential medicines in the globe. And so we are looking at all of that, and... seeking to attract increased funding into the UK."